Earnings History Data for Repare Therapeutics (RPTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Repare Therapeutics
Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | RPTX | Repare Therapeutics | 166.00 | -0.81 | -0.83 | 0.00 | Repare Therapeutics GAAP EPS of -$0.81 [11/7/2024 9:31 AM] |
3.51 | -0.10 (-2.77%) |
3.58 | -0.03 (-0.78%) |
2.71 - 8.49 | 130,876 | 70,000 | 346 | ||
| 06-08-2024 | AH | RPTX | Repare Therapeutics | 140.00 | -0.82 | -0.85 | 0.00 | Repare Therapeutics GAAP EPS of -$0.82 beats by $0.03, revenue of $1.07M misses by $1.86M [8/6/2024 5:26 PM] |
3.00 | -0.23 (-7.12%) |
3.23 | 0.0 (0.00%) |
2.95 - 13.85 | 139,444 | 90,000 | 565 | ||
| 07-05-2024 | AH | RPTX | Repare Therapeutics | 146.00 | 0.30 | -0.10 | 0.00 | Repare Therapeutics GAAP EPS of $0.30 beats by $0.32, revenue of $52.4M beats by $14M [5/7/2024 5:49 PM] |
3.75 | 0.47 (14.33%) |
3.92 | 0.64 (19.51%) |
2.98 - 13.85 | 2,384,234 | 120,000 | 2,120,290 | ||
| 28-02-2024 | PM | RPTX | Repare Therapeutics Inc. | 267.10 | -0.67 | -0.56 | -0.75 | Repare Therapeutics GAAP EPS of -$0.67 misses by $0.34, revenue of $13.05M misses by $5.88M [2/28/2024 7:50 AM] |
6.63 | -0.03 (-0.45%) |
0.0 | 0.0 (0.00%) |
3.08 - 13.85 | 108,823 | 150,000 | 0 | ||
| 09-11-2023 | PM | RPTX | Repare Therapeutics Inc. | 183.95 | -0.45 | -0.86 | 1.71 | Repare Therapeutics GAAP EPS of -$0.45 beats by $0.43, revenue of $2.16M misses by $4.15M [11/9/2023 7:50 AM] |
3.67 | -0.44 (-10.71%) |
4.40 | 0.20 (4.77%) |
3.08 - 18.68 | 283,608 | 560,000 | 3,621 | ||
| 09-08-2023 | AH | RPTX | Repare Therapeutics | 343.00 | -0.28 | -0.83 | 0.00 | Repare Therapeutics GAAP EPS of -$0.28 beats by $0.52, revenue of $30.25M beats by $22.57M [8/9/2023 5:46 PM] |
9.85 | 1.43 (16.98%) |
9.10 | 0.68 (8.08%) |
8.02 - 18.68 | 183,332 | 100,000 | 6,186 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
RPTX | Repare Therapeutics | 447.00 | -0.83 | -0.84 | 0.00 | Repare Therapeutics GAAP EPS of -$0.83 misses by $0.03, revenue of $5.67M misses by $0.45M [5/9/2023 5:39 PM] |
10.61 | 0.08 (0.76%) |
10.53 | 0.0 (0.00%) |
8.06 - 18.68 | 99,866 | 70,000 | 3,404 | |
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
RPTX | Repare Therapeutics | 498.00 | -0.91 | -0.86 | 0.00 | Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06, revenue of $0.67M [8/4/2022 5:27 PM] |
12.53 | -0.60 (-4.57%) |
12.68 | -0.45 (-3.43%) |
8.06 - 35.75 | 520,370 | 210,000 | 1,203 | |
| 05-05-2022 | AH | 4:15 PM ET (May 5) |
RPTX | Repare Therapeutics | 483.00 | -0.83 | -0.89 | 0.00 | Repare Therapeutics GAAP EPS of -$0.83 beats by $0.04, revenue of $0.41M misses by $1.55M [5/5/2022 5:34 PM] |
10.56 | -0.28 (-2.58%) |
10.56 | 0.0 (0.00%) |
9.59 - 35.75 | 185,615 | 180,000 | 655 | |
|
||||||||||||||||||
| 01-03-2022 | AH | After the close (Mar 1) |
RPTX | Repare Therapeutics | 641.00 | -0.70 | -0.75 | 0.00 | Repare Therapeutics GAAP EPS of -$0.70 beats by $0.02, revenue of $6.88M beats by $3.6M [3/1/2022 4:54 PM] |
16.07 | 0.01 (0.06%) |
0.0 | 0.0 (0.00%) |
12.68 - 35.75 | 74,587 | 170,000 | 0 | |
|
||||||||||||||||||
| 13-05-2021 | AH | 4:05 PM ET (May 13) |
RPTX | Repare Therapeutics Inc. | 1,217 | -0.58 | -0.49 | 0.00 | Repare Therapeutics EPS misses by $0.04, misses on revenue [5/13/2021 5:16 PM] |
32.26 | 1.07 (3.43%) |
0.0 | 0.0 (0.00%) |
21.45 - 46.44 | 65,437 | 110,000 | 0 | |
| 04-03-2021 | AH | RPTX | Repare Therapeutics Inc. | 1,240 | -0.41 | -0.41 | 0.00 | Repare Therapeutics EPS beats by $0.04, misses on revenue [3/4/2021 5:43 PM] |
27.33 | -0.09 (-0.33%) |
27.05 | -0.37 (-1.35%) |
21.45 - 46.44 | 237,896 | 152,159 | 247 | ||
| 11-11-2020 | AH | RPTX | Repare Therapeutics Inc. | 1,030 | -0.37 | -0.41 | 0.00 | Repare Therapeutics EPS beats by $0.06 [11/11/2020 4:20 PM] |
27.40 | -0.34 (-1.23%) |
28.50 | 0.76 (2.74%) |
21.45 - 36.67 | 74,082 | 85,976 | 490 | ||
|
|
||||||||||||||||||